RNASEH1 and ovarian carcinoma: To our expect, we observed an expression pattern of high A3B but low RNASEH1 in prexasertib (Chk1i) sensitive ovarian cancer cell lines, in contrast to that of prexasertib-resistant cell lines (Fig. 6K).